Tonix Pharmaceuticals Statistics
NASDAQ: TNXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.38-0.17 (-6.67%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tonix Pharmaceuticals by the numbers
Tonix Pharmaceuticals has a market capitalization of $46.2 million based on 19.43M shares outstanding. With trailing EPS of $-12.39, Tonix Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 64.6% below its 50-day average and 79.2% below its 200-day average.
Average daily trading volume is 838.83K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TNXP valuation vs. peer median
| Metric | TNXP | Peer median | Difference |
|---|---|---|---|
| Market cap | $46.25M | $46.10M | +0% |
| Avg. volume | 838.83K | 671.88K | +25% |
Peer median across 8 companies: MIST, HOWL, RNXT, VRCA, NMAD, APLM, ONCY, QUCY.
Valuation
- Market cap
- $46.25M
- Price / sales (latest FY)
- 3.53
- EPS (TTM)
- $-12.39
- Shares outstanding
- 19.43M
Price and trading
- Previous close
- 2.55
- Open
- 2.56
- Day range
- 2.30 – 2.63
- 52-week range
- 2.30 – 20.56
- 52-week change
- -85.22%
- Beta
- —
- Volume
- 1.26M
- Average volume
- 838.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 46.25M
- Forward Pe
- -0.34
- Eps
- -12.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.56
- Week52 Low
- 2.30
- Avg Volume
- 838.83K
- Shares Outstanding
- 19.43M
- Ma50
- 6.72
- Ma200
- 11.45
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -88.42%
- Pct From52w Low
- 3.48%